Link to this page
Medical Subject Headings
Last uploaded:
March 22, 2026
| Id | http://purl.bioontology.org/ontology/MESH/C045749
http://purl.bioontology.org/ontology/MESH/C045749
|
|---|---|
| Preferred Name | SQ 29548 |
| Synonyms |
SQ 28053
SQ26538
SQ-29548
SQ-26,538
SQ-28053
7-(3-((2-((phenylamino)carbonyl)hydrazino)methyl)-7-oxabicyclo(2.2.1)hept-2-yl)-5-heptenoic acid
SQ-26538
SQ 26538
SQ26,538
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| altLabel |
SQ 28053
SQ26538
SQ-29548
SQ-26,538
SQ-28053
7-(3-((2-((phenylamino)carbonyl)hydrazino)methyl)-7-oxabicyclo(2.2.1)hept-2-yl)-5-heptenoic acid
SQ-26538
SQ 26538
SQ26,538
See more
See less
|
|---|---|
| prefLabel | SQ 29548
|
| II | D017482/Q000037
|
| Scope Statement | SQ-26538 is the ((1S-1alpha,2beta(5Z),3beta(1E,3R*),4alpha))-isomer; thromboxane A2 antagonist; thromboxane receptor antagonist
|
| type | |
| tui |
T109
T121
|
| HM |
D005231
D006834
D019086
|
| SC | 1
|
| TERMUI |
T162890
T517480
T517481
T162892
T517484
T162893
T517482
T517483
T162894
T162891
See more
See less
|
| TH |
NLM (2002)
FDA SRS (2017)
NLM (1985)
|
| SRC | Prostaglandins 1985;29(5):785
|
| MMR | 20180921
|
| notation | C045749
|
| Semantic type UMLS property | |
| RR | 98299-61-7 (SQ 29548)
|
| cui |
C0143419
C0143423
C0099645
C0143371
|
| MeSH Frequency | 517
|
| DSC | 19850819
|
| Inverse of RB |
88SD2J5ZNX
0
|
| Mapped to | |
| MDA | 19850819
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |